Khavinson Bioregulators (Epitalon, Pinealon)

Navigation

Upward Index: 02 - Compounds & Molecules MOC | Literature Dossier: Khavinson Bioregulators (Epitalon, Pinealon) - References

---

1. Pharmacodynamics & Mechanism of Action

Developed at the St. Petersburg Institute of Bioregulation and Gerontology by Prof. Vladimir Khavinson, peptide bioregulators are ultra-short di-, tri-, and tetrapeptides ($2\text{–}4$ amino acids, molecular weight $<500\text{ Da}$) isolated from or modeled on tissue-specific polypeptide extracts (Cytomedines).

• Epigenetic Chromatin Decondensation & Promoter Binding: Because ultra-short peptides are smaller than the pore diameter of the nuclear pore complex, they enter both the cytoplasm and the cell nucleus via PepT1/PepT2 proton-coupled oligopeptide transporters. Biophysical modeling and circular dichroism studies indicate that specific tri/tetrapeptides bind complementary motifs in the minor groove of double-stranded DNA and interact with linker Histone H1 and core Histone H4—inducing localized heterochromatin-to-euchromatin unfolding (decondensation) in senescent cells and restoring tissue-specific gene transcription.
• Epitalon / Epithalon (Ala-Glu-Asp-Gly / AEDG): Synthetic tetrapeptide modeled on the bovine pineal gland polypeptide extract Epithalamin.
  • Telomerase (hTERT) Induction: Induces the expression of the catalytic subunit of human Telomerase Reverse Transcriptase (hTERT) in telomerase-negative human somatic fibroblasts, elongating telomeres by an average of $+33.3\%$ and allowing cells to bypass the Hayflick limit (continuing past 34 population doublings to $>44$ doublings without malignant transformation).
  • Pineal Circadian Restoration: Upregulates pineal Arylalkylamine N-Acetyltransferase (AANAT) and pCREB transcription, restoring nocturnal melatonin synthesis and normalizing flattened diurnal cortisol rhythms in aged primates and humans.
• Pinealon (Glu-Asp-Arg / EDR): Synthetic neuroprotective tripeptide targeting the cerebral cortex.
  • Neuronal Anti-Apoptosis & Dendritic Spine Preservation: Suppresses neuronal reactive oxygen species (ROS) accumulation, inhibits Caspase-3 activation, activates the MAPK/ERK pro-survival cascade, and upregulates Tryptophan Hydroxylase-2 (TPH2) ($5\text{-HT}$ synthesis) and Irisin (FNDC5) gene expression.
• Companion Tissue-Specific Bioregulators:
  • Thymalin / Vilon (Lys-Glu / KE): Thymic immune rejuvenation, T-cell differentiation, and euchromatin activation.
  • Cortagen (Ala-Glu-Asp-Pro / AEDP): Cerebral cortex & peripheral nerve regeneration (modeled on Cortexin).
  • Vesugen (Lys-Glu-Asp / KED) & Ventfort: Vascular endothelial homeostasis and Ki-67 endothelial renewal.
  • Bronchogen (Ala-Glu-Asp-Leu / AEDL) & Cardiogen (Ala-Glu-Asp-Arg / AEDR): Bronchial and myocardial fibroblast remodeling.

---

2. Pharmacokinetics & Transport Mechanics

• PepT1 / PepT2 Transporter Entry: Di- and tripeptides (like Vilon and Pinealon) and select tetrapeptides are absorbed intact across intestinal enterocytes, the blood-brain barrier, and cellular/nuclear membranes via SLC15A1 (PepT1) and SLC15A2 (PepT2) oligopeptide transporters without requiring endocytic receptor internalization.
• Dosing Discrepancy Note (Epitalon vs. Epithalamin): A frequent biohacking error is confusing the dosing of crude bovine pineal extract Epithalamin ($10\text{ mg/day}$ IM, which contains $<10\%$ active short peptides by weight) with pure synthetic Epitalon (AEDG). In Khavinson’s comparative primate and cell studies, pure Epitalon is active at $100\text{–}1,000\times$ lower concentrations ($0.1\text{–}1.0\text{ mg/day}$ SubQ or up to $5\text{ mg/day}$ for 10 days), making $10\text{ mg/day}$ daily protocols unnecessarily high.

---

3. Dosing, Cycling & Synergies

• Standard Protocol (Biannual Pulse Protocol):
  • Epitalon (Synthetic AEDG): $1.0\text{–}5.0\text{ mg/day}$ SubQ (or intranasally) for 10 to 20 consecutive days, repeated twice per year (every 6 months). Administer in the evening ($2\text{ hours}$ before bed) or morning if initial circadian phase-shifting temporarily increases dream intensity.
  • Pinealon (Synthetic EDR): $1.0\text{–}2.0\text{ mg/day}$ SubQ/intranasal (or $10\text{–}20\text{ mg/day}$ oral capsules) for 10 to 20 consecutive days, pulsed 2–3 times per year.
  • Synergistic Pineal-Thymic Longevity Pulse: Pair Epitalon ($2\text{ mg/day}$) with Thymalin ($5\text{–}10\text{ mg/day}$ polypeptide or Vilon $1\text{ mg/day}$ dipeptide) for 10 days twice yearly (mirroring the 12-to-15-year human mortality trials).
• Contraindications & Biomarkers to Monitor:
  • Precautions: While Khavinson’s rodent bioassays showed Epitalon decreased spontaneous tumor incidence (via melatonin/immune surveillance restoration), caution is advised with any telomerase activator in active oncology.
  • Biomarkers: 6-Sulfatoxymelatonin (aMT6s) in first-morning urine (direct index of nocturnal pineal melatonin output), 4-Point Diurnal Cortisol, Lymphocyte Subset Panel (${\text{CD4}}^{+}/{\text{CD8}}^{+}$ ratio), and Leukocyte Telomere Length (qPCR / Flow-FISH) + Epigenetic GrimAge/DunedinPACE clocks.

---

4. Key Scientific Evidence Summary

• Human Somatic Telomerase & Telomere Elongation: Khavinson et al. (2003) and Anisimov et al. demonstrated in Bulletin of Experimental Biology and Medicine that Epitalon induces telomerase activity in telomerase-negative human fetal fibroblasts (line 602/17), elongating telomeres by $+33.3\%$ and extending replicative lifespan past the 34-division Hayflick limit to $>44$ divisions.
• Primate & Elderly Human Melatonin Restoration: Korkushko et al. (2006) and Goncharova et al. (2005) showed that Epitalon/Epithalamin restores nocturnal plasma melatonin by $+2\text{- to }3\text{-fold}$ in aged rhesus monkeys and elderly humans while normalizing pancreatic insulin response.
• Long-Term Human Mortality Reduction (Epithalamin + Thymalin): Korkushko et al. and Khavinson & Morozov (2003) reported in a 6-to-12-year randomized prospective clinical study in elderly cardiovascular patients ($N=266$) that biannual courses of Epithalamin and Thymalin reduced all-cause mortality by $1.6\text{- to }2.1\text{-fold}$ (and up to $4.1\text{-fold}$ in combined pineal+thymic cohorts).

See full study breakdowns in Khavinson Bioregulators (Epitalon, Pinealon) - References.